Earnings Miss Has Canopy Growth on the Outside Looking in

Should investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip or heed the warnings the market is putting out today?

| More on:

Canopy Growth (TSX:WEED)(NYSE:CGC) had an impressive start to the year. Indeed, Canopy Growth saw its stock price increase from under $25 per share to start the year to more than $70 per share in February. A near-tripling in approximately one month is some pretty insane momentum indeed.

However, of late, shares of Canopy are back to trading below $30 per share. Accordingly, investors looking for hyper-growth stocks at more reasonable prices may be enticed by this stock right now.

Let’s discuss why the drop has taken place and whether loading up on Canopy stock right now is a good idea.

Fourth-quarter earnings failed to meet analysts’ estimates

For companies in incredibly high-growth segments such as cannabis, quarterly earnings mean more than for, say, a company that’s been around for 100 years and is operating in a mature industry, paying a large dividend. That’s because the company’s growth trajectory matters much more to investors that anything else.

This past quarter didn’t really get investors excited. Canopy Growth reported revenue of approximately $148 million. This amounted to a 38% growth rate year over year. That’s decent but really not what investors were hoping for. On a quarter-over-quarter basis, this only amounted to a 3% increase.

Additionally, Canopy Growth’s net loss during the quarter was a whopping $616 million. That’s more than four times what the company brought in in terms of revenue.

These losses are starting to pile up, and Canopy Growth’s $1.67 billion loss for this past fiscal year highlights the profitability concern many investors have with this stock. Yes, the majority of these losses were due to asset and inventory impairment charges. However, these impairment charges indicate the company’s relatively lax capital-allocation processes.

Accordingly, Canopy Growth is now in a position where it’s focusing more on cutting costs than generating growth. This sort of a situation obviously isn’t good for long-term growth investors in such stocks.

Bottom line

Canopy Growth’s financials are finally starting to bite investors on the behind.

Indeed, this company’s growth story has been overshadowed by its poor capital-allocation choices in the past. The company projects it will burn approximately $400 million next year and $125 million in 2023. That level of cash burn means investors are likely to wait three or more years to see positive cash flow materialize. That’s a heck of a lot longer than many initially expected.

Couple this reality with the fact that U.S. legalization may take a while to materialize, if at all, and there’s a tsunami of reasons to not jump into WEED stock quite yet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »